Cite
When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment
MLA
Wen-Chien Cheng, et al. “When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment.” International Journal of Chronic Obstructive Pulmonary Disease, vol. 15, Dec. 2020, pp. 3375–84. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....40d1c3a1c43ae6a1bb67ff4d5df786a6&authtype=sso&custid=ns315887.
APA
Wen-Chien Cheng, Wu-Huei Hsu, Chih-Yu Chen, Biing-Ru Wu, Wei Chun Chen, Chia-Hung Chen, Chih Yen Tu, Te Chun Hsia, & Wei-Chih Liao. (2020). When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment. International Journal of Chronic Obstructive Pulmonary Disease, 15, 3375–3384.
Chicago
Wen-Chien Cheng, Wu-Huei Hsu, Chih-Yu Chen, Biing-Ru Wu, Wei Chun Chen, Chia-Hung Chen, Chih Yen Tu, Te Chun Hsia, and Wei-Chih Liao. 2020. “When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment.” International Journal of Chronic Obstructive Pulmonary Disease 15 (December): 3375–84. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....40d1c3a1c43ae6a1bb67ff4d5df786a6&authtype=sso&custid=ns315887.